ICP-332 in Subjects With Non-segmental Vitiligo

Recruiting now · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Non Segmental Vitiligo

In brief

This a phase II/III randomized, double-blind, placebo-controlled, parallel group, adaptive design, multi-center study to evaluate the efficacy and safety of ICP-332 in subjects with non-segmental vitiligo。The study consisted an phase 2 part and an phase 3 part.

Key facts

Study ID
NCT07047612
Run by
Beijing InnoCare Pharma Tech Co., Ltd.
People needed
603
Starts
2025-05-09
Expected to finish
2029-04-01
Last updated by the study team
2025-08-07

Who can join

Age: 12 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.